Sean E. Aeder

Array ( [id] => 8359530 [patent_doc_number] => 20120214691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Methods for Diagnosing Breast Cancer Using miR-21, miR-125-1, miR-125b-2 and miR-145' [patent_app_type] => utility [patent_app_number] => 13/405557 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31605 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359531 [patent_doc_number] => 20120214688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Methods for Diagnosing Breast, Colon, Lung, Pancreatic and Prostate Cancer Using miR-21 and miR-17-5p' [patent_app_type] => utility [patent_app_number] => 13/405517 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31593 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359538 [patent_doc_number] => 20120214690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Methods for Diagnosing Colon, Stomach, Prostate and Pancreas Cancer Using miR-223' [patent_app_type] => utility [patent_app_number] => 13/405543 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31536 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358671 [patent_doc_number] => 20120213822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'CHEMO-IMMUNOTHERAPY METHOD' [patent_app_type] => utility [patent_app_number] => 13/401377 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30895 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13401377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269634 [patent_doc_number] => 20140024552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/985140 [patent_app_country] => US [patent_app_date] => 2012-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10278 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8744586 [patent_doc_number] => 20130084302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'Methods of binding TNF-alpha using Anti-TNF-alpha antibody fragment-polymer conjugates' [patent_app_type] => utility [patent_app_number] => 13/372191 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 144 [patent_figures_cnt] => 144 [patent_no_of_words] => 111778 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227368 [patent_doc_number] => 20120141560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'TUMOR AND INFECTIOUS DISEASE THERAPEUTIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/372005 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20530 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227273 [patent_doc_number] => 20120141482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'MOLECULAR COMPLEXES WHICH MODIFY IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 13/369429 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17423 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10961297 [patent_doc_number] => 20140364326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'COMBINATORIAL BIOMARKERS FOR CLINICAL APPLICATIONS IN LUNG CANCER PATIENT MANAGEMENT' [patent_app_type] => utility [patent_app_number] => 13/981725 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11681 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227249 [patent_doc_number] => 20120141462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 13/354774 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14283 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253005 [patent_doc_number] => 20120157335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Flap Endonuclease-1 As A Marker For Cancer' [patent_app_type] => utility [patent_app_number] => 13/351801 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15412 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157335.pdf [firstpage_image] =>[orig_patent_app_number] => 13351801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8697920 [patent_doc_number] => 20130059930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'DIAGNOSTIC METHOD' [patent_app_type] => utility [patent_app_number] => 13/512585 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11825 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857338 [patent_doc_number] => 20150037355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'GENERATION OF ANTIBODIES TO TUMOR ANTIGENS AND GENERATION OF TUMOR SPECIFIC COMPLEMENT DEPENDENT CYTOTOXICITY BY ADMINISTRATION OF ONCOLYTIC VACCINIA VIRUS' [patent_app_type] => utility [patent_app_number] => 13/978113 [patent_app_country] => US [patent_app_date] => 2012-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 15479 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8139525 [patent_doc_number] => 20120094311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'GENE AND PROTEIN EXPRESSION PROFILES ASSOCIATED WITH THE THERAPEUTIC EFFICACY OF EGFR-TK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/334881 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11223 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094311.pdf [firstpage_image] =>[orig_patent_app_number] => 13334881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8159095 [patent_doc_number] => 20120100554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'DETECTING CANCER WITH ANTI-CCL25 AND ANTI-CCR9 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/324669 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21029 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100554.pdf [firstpage_image] =>[orig_patent_app_number] => 13324669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212100 [patent_doc_number] => 20140011277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'NOVEL THERAPEUTIC STRATEGIES FOR IMPROVING AN ANTICANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/993934 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3734 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9054541 [patent_doc_number] => 20130252255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'BLADDER CANCER DIAGNOSIS COMPOSITION CONTAINING APE1/REF-1 AND BLADDER CANCER DIAGNOSTIC KIT USING SAME' [patent_app_type] => utility [patent_app_number] => 13/990798 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3325 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8290305 [patent_doc_number] => 20120178632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'BIOMARKERS FOR IDENTIFYING PATIENT CLASSES' [patent_app_type] => utility [patent_app_number] => 13/311752 [patent_app_country] => US [patent_app_date] => 2011-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19656 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13311752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9922599 [patent_doc_number] => 08980557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Marker for determination of sensitivity to triplet combination anti-cancer agent' [patent_app_type] => utility [patent_app_number] => 13/991318 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11333 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221227 [patent_doc_number] => 20120135429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'PRO-GRP AS A SURROGATE MARKER TO PREDICT AND MONITOR RESPONSE TO BCL-2 INHIBITOR THERAPY' [patent_app_type] => utility [patent_app_number] => 13/309307 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309307 [rel_patent_id] =>[rel_patent_doc_number] =>)